Ginkgo Capex To Operating Cash Flow from 2010 to 2026
| DNA Stock | USD 9.35 0.12 1.30% |
Capex To Operating Cash Flow | First Reported 2010-12-31 | Previous Quarter (0.18) | Current Value (0.18) | Quarterly Volatility 0.15144027 |
Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as Net Interest Income of 46.5 M, Interest Income of 23 M or Depreciation And Amortization of 45.8 M, as well as many indicators such as Price To Sales Ratio of 2.45, Dividend Yield of 0.0 or PTB Ratio of 0.78. Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.
Ginkgo | Capex To Operating Cash Flow | Build AI portfolio with Ginkgo Stock |
Analyzing Ginkgo Bioworks's Capex To Operating Cash Flow over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Capex To Operating Cash Flow has evolved provides context for assessing Ginkgo Bioworks's current valuation and future prospects.
Latest Ginkgo Bioworks' Capex To Operating Cash Flow Growth Pattern
Below is the plot of the Capex To Operating Cash Flow of Ginkgo Bioworks Holdings over the last few years. It is Ginkgo Bioworks' Capex To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ginkgo Bioworks' overall financial position and show how it may be relating to other accounts over time.
| Capex To Operating Cash Flow | 10 Years Trend |
|
Capex To Operating Cash Flow |
| Timeline |
Ginkgo Capex To Operating Cash Flow Regression Statistics
| Arithmetic Mean | (0.38) | |
| Coefficient Of Variation | (39.46) | |
| Mean Deviation | 0.14 | |
| Median | (0.50) | |
| Standard Deviation | 0.15 | |
| Sample Variance | 0.02 | |
| Range | 0.3594 | |
| R-Value | 0.86 | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.74 | |
| Significance | 0.000011 | |
| Slope | 0.03 | |
| Total Sum of Squares | 0.37 |
Ginkgo Capex To Operating Cash Flow History
About Ginkgo Bioworks Financial Statements
Ginkgo Bioworks stakeholders use historical fundamental indicators, such as Ginkgo Bioworks' Capex To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Ginkgo Bioworks investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ginkgo Bioworks' assets and liabilities are reflected in the revenues and expenses on Ginkgo Bioworks' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ginkgo Bioworks Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capex To Operating Cash Flow | (0.20) | (0.18) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:Check out the analysis of Ginkgo Bioworks Correlation against competitors. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. Projected growth potential of Ginkgo fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ginkgo Bioworks assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (6.18) | Revenue Per Share | Quarterly Revenue Growth (0.56) | Return On Assets | Return On Equity |
Understanding Ginkgo Bioworks Holdings requires distinguishing between market price and book value, where the latter reflects Ginkgo's accounting equity. The concept of intrinsic value - what Ginkgo Bioworks' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ginkgo Bioworks' price substantially above or below its fundamental value.
It's important to distinguish between Ginkgo Bioworks' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ginkgo Bioworks should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ginkgo Bioworks' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.